Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Daclatasvir
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05
- Strength
- 60 mg
- Dosage form
- Tablet
- Pack
- 28
- Registration no.
- 089435
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-11 02:59
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Daclata (Daclatasvir) is used for
Daclatasvir is an antiviral medicine for hepatitis C. It belongs to a group called NS5A inhibitors, which stop the hepatitis C virus from spreading in the body. It is always taken together with another hepatitis C medicine, sofosbuvir, and the two together work against all the main types (genotypes) of the virus. It is a prescription medicine: a doctor decides on treatment and checks your progress with blood tests. It is on the WHO list of essential medicines, although it has been withdrawn from sale in the United States and other high-income countries.
- Long-term (chronic) hepatitis C infection in adults, always together with sofosbuvir
- Chronic hepatitis C in children and teenagers, as listed by WHO
- All the main types of hepatitis C virus (genotypes 1 to 6)
- People who have both HIV and hepatitis C, with careful checks of their other medicines
- In Pakistan, which has one of the highest numbers of people with hepatitis C in the world, sofosbuvir with daclatasvir is used as an affordable first-line treatment
Get medical help straight away if
- If you take, or have recently stopped, the heart medicine amiodarone, get urgent medical help for fainting or nearly fainting, dizziness or light-headedness, chest pain, shortness of breath, weakness, confusion or memory problems. Taken together with this treatment, amiodarone can slow the heartbeat dangerously.
- Call your doctor straight away for signs that hepatitis B may be flaring up: unusual tiredness, yellow skin or eyes, loss of appetite, feeling or being sick, pale stools, stomach pain or dark urine. This can happen during treatment or after it ends in people who have ever had hepatitis B.
- If you have diabetes, contact your doctor for signs of low blood sugar, such as shaking, sweating or confusion. Blood sugar control can improve as hepatitis C is treated, so sugar levels may fall.
- Tell your doctor about any other unusual problem while taking it.
Side effects, warnings and interactions for Daclatasvir
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Daclatasvir
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Daclatasvir is right for you and the dose.
- Hepatitis C: first-choice low-cost pangenotypic treatment, the most widely used combination in many low- and middle-income countries
About Daclata 60 mg tablet
Daclata 60 mg tablet contains Daclatasvir 60 mg. It is registered with DRAP by Highnoon Laboratories Ltd (registration no. 089435). Its official price is PKR 9,530.12 for a pack of 28, about PKR 340.36 per tablet. This price has applied since 27 July 2026. Daclata is also available as 30 mg tablet. 29 other brands of Daclatasvir 60 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Daclata
All 29 other brands of Daclatasvir 60 mg tablet in Pakistan
These 29 brands are alternatives (substitutes) to Daclata: each contains Daclatasvir 60 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Daclavir (Dyson Research Laboratories (Pvt.) Ltd) at PKR 289 per tablet; the highest is Dakvir at PKR 345. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Daclavir | Dyson Research Laboratories (Pvt.) Ltd | 28's | PKR 8,079.93 | PKR 289 / tablet |
| Dalavir | Bosch Pharmaceuticals (Pvt) Ltd | 28's | PKR 8,259.53 | PKR 295 / tablet |
| Dac | Werrick Pharmaceuticals | 28's | PKR 8,405.66 | PKR 300 / tablet |
| Declar | Helix Pharma (Pvt)., Ltd | 28's | PKR 8,405.66 | PKR 300 / tablet |
| Daclawil | Wilson's Pharmaceuticals | 28's | PKR 8,405.66 | PKR 300 / tablet |
| Declawin | Shaigan Pharmaceuticals (Pvt) Ltd | 28's | PKR 8,405.66 | PKR 300 / tablet |
| Daclahep | Genome Pharmaceuticals (Pvt.) Ltd | 28's | PKR 8,836.87 | PKR 316 / tablet |
| Bio-Tasvir | Bio-Labs(Pvt) Ltd | 28's | PKR 8,837.50 | PKR 316 / tablet |
| Glinza | Global Pharmaceuticals (Pvt.) Ltd | 28's | PKR 8,837.55 | PKR 316 / tablet |
| Latvir | Neutro Pharma (Pvt.) Ltd | 28's | PKR 8,837.71 | PKR 316 / tablet |
| Dascot | Scotmann Pharmaceuticals | 28’s | PKR 8,837.71 | PKR 316 / tablet |
| D-HEP | Atco Laboratories Limited | 28s | PKR 8,837.71 | PKR 316 / tablet |
| Dasvir | NovaMed Pharmaceuticals(Pvt.)Ltd | 28's | PKR 9,022.64 | PKR 322 / tablet |
| Dowdacla | Martin Dow Limited | 28's | PKR 9,022.64 | PKR 322 / tablet |
| NISITA | TABROS PHARMA (PVT). LTD | 28's | PKR 9,078.99 | PKR 324 / tablet |
| Daclit | M/s. Genix Pharma (Pvt) Ltd | 28's | PKR 9,079.69 | PKR 324 / tablet |
| Daklana | Ferozsons Laboratories Limited | 28's | PKR 9,079.70 | PKR 324 / tablet |
| Daclavir | CRYSTOLITE PHARMACEUTICALS | 28’s | PKR 9,079.86 | PKR 324 / tablet |
| Daclife | Scilife Pharma Private Limited | 28's | PKR 9,080.04 | PKR 324 / tablet |
| Dactovi | The Searle Company Limited | 28's | PKR 9,183.98 | PKR 328 / tablet |
Show all 29 brands
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| CLAVIR | Hilton Pharma (Pvt) Limited | 28's | PKR 9,267.83 | PKR 331 / tablet |
| MYDEKLA | AGP Limited | 28's | PKR 9,267.84 | PKR 331 / tablet |
| Daklavin | Pharmasol (Pvt) Ltd | 28's | PKR 9,268.73 | PKR 331 / tablet |
| Daclaget | Getz Pharma (Pvt) Limited | 28's | PKR 9,268.91 | PKR 331 / tablet |
| DEVAZO | SAMI Pharmaceuticals Pvt. Ltd | 28s | PKR 9,344.25 | PKR 334 / tablet |
| Maclinza | Macter International Limited | 28's | PKR 9,344.27 | PKR 334 / tablet |
| Dasavir | Aspin Pharma | 28's | PKR 9,376.32 | PKR 335 / tablet |
| Livanza | The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd | 28's | PKR 9,637.12 | PKR 344 / tablet |
| Dakvir | PHARMEVO (PVT) LTD | 4x7's Pack | PKR 9,649.17 | PKR 345 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Daclata, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Highnoon Laboratories Ltd, Lahore
- DRAP registration
- 089435
- Phone
- +92 42 111 000 465
- info@highnoon.com.pk
- Website
- https://highnoon-labs.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (28). Current price PKR 9,530.12, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Daclata 60 mg, 28: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/daclata-60-mg-089435-28-highnoon-laboratories-ltd/ (accessed 11 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 9,530.12 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 089435Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.